Starjemza (Ustekinumab) FDA Approval: 2025’s First Biosimilar for Stelara in Psoriasis Care
Автор: Xtalks
Загружено: 2025-06-02
Просмотров: 456
Описание:
The FDA has approved Starjemza (ustekinumab-hmny) injection, a biosimilar referencing Janssen’s Stelara (ustekinumab).
Developed by Bio-Thera Solutions, Ltd. and to be commercialized in the US by Hikma Pharmaceuticals, Starjemza is indicated for adults and children (6 years and older) with moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn’s disease and ulcerative colitis.
Read more here: http://xtalks.com/starjemza-ustekinum...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: